Day: May 13, 2020

BATON ROUGE, La., May 13, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at RBC Capital Markets 2020 Global Healthcare Conference on Tuesday, May 19, 2020.The presentation will begin at 1:20 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering...

LOS ANGELES, May 13, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (“Capricor”) (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment and prevention of diseases, today announced that it will release its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, May 14, 2020. Company management will host a conference call and webcast with slides to discuss its financial results and provide a general business update at 4:30 p.m. (ET) on the same day.About Capricor TherapeuticsCapricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment and prevention of diseases. Capricor’s...

MINNEAPOLIS, May 13, 2020 (GLOBE NEWSWIRE) — BBQ Holdings, Inc. (NASDAQ: BBQ) (the “Company”), an innovating global owner and operator of restaurants, today reported financial results for the first fiscal quarter ended March 29, 2020.  Note: The First Quarter results were affected by the COVID-19 pandemic as well as federal and state level mandates requiring stores to convert to To-go only business.First Quarter 2020 Highlights:Company-owned Famous Dave’s same store net sales decreased 6.8%.Prior to the closure of our dining rooms mid-March same store net sales increased 3.0%.Franchise-operated same store net sales decreased 13.1%.Prior to the closure of dining rooms, Famous Dave’s franchise-operated same store net sales decreased $2.0%.Same store To-go sales increased 8.4% at Company-owned Famous Dave’s restaurants.Closed the Granite...

AUSTIN, Texas, May 13, 2020 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that management will participate in the Bank of America Securities Virtual Healthcare Conference and the UBS Virtual Healthcare Conference.About Molecular Templates Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Molecular Templates’ proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like...

MONTREAL and SARASOTA, Fla., May 13, 2020 (GLOBE NEWSWIRE) — Intertape Polymer Group Inc. (TSX:ITP) (“IPG” or the “Company”) today announced the voting results from its annual meeting of shareholders (the “Meeting”) held on May 13, 2020.All nine nominees listed in its management information circular dated March 27, 2020 were elected as Directors of the Company at the Meeting. The results of the vote are set out below:The complete biographies of the elected Directors and further details about the Company’s corporate governance practices are available at www.itape.com.At the Meeting, Raymond Chabot Grant Thornton LLP was re-appointed as auditor of the Company.The shareholders adopted a resolution accepting, in an advisory, non-binding capacity, the Company’s approach to executive compensation disclosed under “Compensation of Executive...

LIVERMORE, Calif., May 13, 2020 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading semiconductor test and measurement supplier, announced that it has once again been named a 10 BEST and THE BEST Supplier in VLSIresearch’s annual customer satisfaction survey in three categories;10 BEST Focused Suppliers of Chip Making Equipment,THE BEST Suppliers of Test Equipment, andTHE BEST Suppliers of Test Subsystems.The survey includes the feedback of worldwide semiconductor manufacturing companies, rating suppliers in 14 categories, and measuring in each – supplier performance, customer service and product performance. The results mark seven consecutive years that FormFactor has been selected in THE BEST Suppliers of Test Subsystems which includes manufacturers of probe cards, test sockets and device interface boards. In April,...

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) —All per share figures disclosed below are stated on a diluted basis.During the current quarter, the COVID-19 pandemic caused a series of events which led to significant disruptions in the global financial markets and economies.  Although the Company was not immune to the negative impact, its operating business segments have shown resiliency during this challenging period. The diversification of the Company’s businesses and revenue sources has helped to shield its Operating earnings from the full impact of the pandemic. The significant, rapid decline in the public equities markets towards the end of Q1 2020, especially its impact on the value of Bank of Montreal shares, posed the greatest stress to the Company’s financial position and results.  The write down in the fair value of the Securities...

GAITHERSBURG, Md., May 13, 2020 (GLOBE NEWSWIRE) — Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today reported financial results and provided program highlights for the first quarter ended March 31, 2020.“With the PDUFA date for our lead product candidate, inebilizumab, approaching in about one month, we are nearing another major company milestone—our first potential U.S. regulatory approval,” said Bing Yao, Ph.D., Chief Executive Officer at Viela Bio. “In anticipation, our field teams have been hard at work continuing to prepare for the potential product launch. Based on positive efficacy and safety data in the pivotal N-MOmentum trial—which studied a broad, real-world spectrum of adults with neuromyelitis optica spectrum disorder, or NMOSD—we...

NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) virtually due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of meeting participants.The Annual Meeting will be held in a virtual-only format on May 27, 2020, at 10:00 a.m., Eastern Time. Stockholders will not be able to attend the Annual Meeting in person, however, stockholders of record and registered beneficial owners as of the close of business on April 6, 2020, will be able to vote and ask questions during the meeting through the online platform.Attending...

ROLLING MEADOWS, Ill., May 13, 2020 (GLOBE NEWSWIRE) — Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of wireless networking infrastructure solutions, announced today that, due to the public health and safety concerns related to the novel coronavirus (COVID-19) pandemic and recommendations from government authorities, the location of the Company’s 2020 Annual Meeting of Shareholders (including any adjournments or postponements, the “Annual Meeting”) has been changed to a virtual-only format.As previously announced, the Annual Meeting will be held at 10:00 a.m. Pacific Time on Wednesday, June 3, 2020. Shareholders will not be able to attend the Annual Meeting in person. In order to attend the Annual Meeting virtually, shareholders must register in advance at https://www.proxydocs.com/CMBM prior...